DOCSLIB.ORG

AAI Expands Travel Awards and Outreach Programs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AAI Expands Travel Awards and Outreach Programs In This Issue… AUGUST 2015 3 3 FocusAAI President’s on Public Profile Affairs: 4 nFocus Government on Public Re-opensAffairs AAI Expands Travel Awards and Outreach Programs 8 Membersafter 16-Day in the News Shutdown n AAIFour Recognizes Elected to National 2013 Commitment Bolsters Support for Members’ Participation in PublicAcademy Service of Sciences: Award HonoreesJean-Laurent Casanova Regional, International Immunology Meetings 6 AAIWarren Council Leonard Welcomes New CouncillorShigekazu JoAnne Nagata Flynn 7 JoAnneLalita L.Ramakrishnan Flynn’s 2013 AAI Candidate’sLawrence StatementSteinman 813 Members2015 Careers in the in Immunology News Fellows Announced n Randy Brutkiewicz 18 Summer 2015 Travel for n Ruslan Medzhitov Techniques Awardees Members Awarded AAI Travel n Joshua Obar 19 AAI Travel Grants for 4th Grants for 4th European Congress 13 In Memoriam: European Congress of in Vienna – See page 19 Yacov Ron, Ph.D. Immunology Announced 14 AAI Looks Back 20 AAI to Offer Members $1 22 MillionmyIDP inPrepares Travel Grants Trainees for to Transition to the 16th ICI “Final Frontier” 2521 Re-Cap:Outreach Summer Program 2013Update AAI 22 AAIIntroductory Looks Back: Immunology Diseases andCourse Institutions that Shaped 26 Re-Cap:Immunology Summer in Louisiana 2013 AAI 26 HighlightsAdvanced ofImmunology 2015 AAI BusinessCourse Meeting 28 AAI Members and Staff 33 Grant & Award Deadlines Participate in 15th ICI 36 Meetings Calendar 30 AAI Announces Tiered Awards for the 2014 Trainee Abstract Award Program 32 Grant & Award Deadlines 34 Meetings & Events Calendar AAI to Offer Members $1 Million in Travel Grants for 16th International Congress in Melbourne – See page 20 IMMUNOLOGY 2016 ™ MAY 13-17, 2016 WASHINGTON STATE CONVENTION CENTER SEATTLE, WA SAVE THE DATE 2www. AAI IMMUNOLOGY2016Newsletter .org June 2015 ™ 99TH AAI PRESIDENT’S PROFILE IMMUNOLOGY 2016 Dan R. Littman, hopes of fi nding ways to promote specifi c types of immune M.D., Ph.D., AAI ’87 responses in specifi c situations. AAI President, July 2015 – Littman was the 2010 AAI-Invitrogen Meritorious Career June 2016 Award honoree for outstanding research contributions to the fi eld of immunology. Littman is also a past AAI HHMI Investigator and Distinguished Lecturer and has served as an AAI President’s Kimmel Professor of Molecular Symposium speaker and AAI major symposium chair and SAVE THE DATE Immunology speaker at the AAI annual meeting. He has served as a Skirball Institute member of the AAI Awards Committee, AAI Nominating of Biomolecular Medicine Committee, and AAI Program Committee. New York University School Littman is an elected member/fellow of the National of Medicine Academy of Sciences, Institute of Medicine (renamed r. Littman, a member of the AAI Council since his National Academy of Medicine, 2015), the American Delection in 2010, is the 99th president of AAI, leading Academy of Arts and Sciences, the Association of American the association during the July 2015–June 2016 term. Physicians, and the American Academy of Microbiology. He has served on numerous review and advisory panels on A Howard Hughes Medical Institute (HHMI) investigator behalf of NIH (including the NIH AIDS Vaccine Research since 1995, Littman is the Helen L. and Martin S. Kimmel Committee, National Cancer Institute Board of Scientifi c Professor of Molecular Immunology in the Departments Councilors, NIH Immunobiology Study Section, NIH of Pathology and Microbiology at the New York University Director’s Opportunity 5 Themes Infectious Diseases) School of Medicine’s Skirball Institute of Biomolecular as well as on behalf of the Jackson Laboratories, Lasker Medicine, where he also serves as coordinator of the Awards; Jane Coffi n Childs Memorial Fund for Medical Molecular Pathogenesis Program. Research; Rainin Foundation; Cold Spring Harbor Littman’s laboratory investigates the molecular events conferences; Research Institute of Molecular Pathology, underlying T lymphocyte differentiation and activation Vienna; Max Planck Institute; Pew Scholars Program; and the mechanisms by which symbiotic bacterial species Damon Runyon Ratchleff Innovation Award; New York infl uence immune responses. Littman’s early work included Stem Cell Foundation; La Jolla Institute for Allergy and key discoveries regarding T cell coreceptors and how Immunology; the Harvey Society (including as board HIV uses CD4 and CCR5 to enter target T cells. His group president); Damon Runyon Cancer Research Foundation; has also studied how HIV causes systemic depletion of Institute for Research in Biomedicine, Bellinzona; Memorial helper T cells and subverts normal immune defenses to its Sloan Kettering Cancer Center; DNAX Research Institute; advantage, and has more recently worked to understand Gordon Conference (immunology); Centre d’Immunologie, how commensal microbiota modulate responses against Marseille-Luminy; Irvington Institute; Searle Scholars pathogenic viruses such as HIV. At a more basic level, program; Israel Cancer Research Fund; Cancer Research Littman’s lab works to understand the mechanisms of Institute; and American Cancer Society (California). His the transcription factors that activate gene expression current and past editorial board appointments include programs and the epigenetic mechanisms that lock in service on behalf of the Annual Review of Immunology these programs through analyzing the development of T (current Co-Editor-in-chief), Cell, Immunity, and lymphocytes and their responses to infl ammatory microbial International Immunity. signals. They elucidated mechanisms of CD4 vs. CD8 T cell His additional career honors and appointments include: lineage specifi cation in the thymus including regulation by senior fellow, Simons Foundation Society of Fellows; Ross the transcription factors Runx1, Runx3, and ThPOK, and Prize in Molecular Medicine; the New York City Mayor’s Prize also identifi ed the importance of the transcription factor for Excellence in Science and Technology; NIH Director’s RORγt and other transcriptional and post-transcriptional Lecture; NIH MERIT Award; the Searle Scholar Award, regulatory networks in the differentiation of Th17 cells and Chicago Community Trust; Bernard Amos Memorial Lecture, IL-22-producing innate lymphoid cells. They found that a Duke University; Richard C. Parker Memorial Lecture, commensal gut microbe, segmented fi lamentous bacteria Columbia University; Carl Vernon Moore Memorial Lecture, (SFB), induced differentiation of Th17 cells, leading both to Washington University; Newton-Abraham Visiting Professor, protection against infection and induction of autoimmune University of Oxford; Harvey Society Lecture, New York; disease. Ongoing research seeks to determine which Peter Doherty Lecture, St. Jude Children’s Research Hospital; commensal bacteria are helpful and which are harmful in a Charles A. Stuart Memorial Lecture, Brown University; multitude of infl ammatory and autoimmune situations in See 99th AAI President’s Profile, p. 35 www.IMMUNOLOGY2016.org www.aai.org AAI Newsletter 3 FOCUS ON PUBLIC AFFAIRS AAI Holds Fourth Annual Public Policy AAI Launches Fifth Year of Public Fellows Capitol Hill Day Policy Fellows Program Earlier this year, the 2014–2015 class of AAI Public May 1 marked the beginning of the fi fth year of the AAI Policy Fellows traveled to Washington, D.C., to participate Public Policy Fellows Program (PPFP). The PPFP is designed in the fourth to engage eligible postdoctoral fellows and junior scientists annual AAI in public policy and legislative activities that impact Public Policy biomedical research. To date, 40 early-career scientists from Fellows 24 different states have completed the program. Program AAI is pleased to welcome the following AAI members to Capitol Hill the 2015–16 PPFP: Day. Tullia Bruno, Ph.D., University of Colorado School of The 10 AAI Medicine Fellows were joined by AAI Jason Gigley, Ph.D., University of Wyoming Committee AAI Fellows, leaders, and staff gathered on Capitol Hill Nichol Holodick, Ph.D., The Feinstein Institute for on Public Medical Research Affairs Chair Clifford V. Harding, M.D., Ph.D., and AAI David Larson, Ph.D., University of Hawaii Cancer Center Advocacy Programs Subcommittee Chair Susanna Greer, Ph.D. The program opened on the evening of March 10 Jean Nepomuscene Manirarora, D.V.M., Ph.D., FDA with a working dinner. National Institute of Allergy and Center for Biologics Evaluation and Research Infectious Diseases (NIAID) Principal Deputy Director Meghan Marré, Ph.D., University of Pittsburgh Hugh Auchincloss, M.D. (AAI ’83), was the special guest speaker for the fourth consecutive year. Auchincloss Nicole Perry, Ph.D., Seattle Children’s Research Institute provided a behind-the-scenes perspective on NIH and Erica Stone, Ph.D., The Wistar Institute NIAID and Joshua Vieth, Ph.D., Child Health Institute of New Jersey/ led a lively Rutgers University discussion with the Jessica Werner, Ph.D., University of Michigan Fellows. For more information about the AAI PPFP, please visit The second http://aai.org/Public_Affairs/PPFP/index.html. presentation was given by Lauren Alternative Funding Sources Discussed Gross, J.D., during Public Affairs Session at (L-R): AAI Fellows Ryan Cummings and AAI Director Heather Kling, AAI Director of Public Policy of Public IMMUNOLOGY 2015™ and Government Affairs Lauren Gross, Policy and AAI Fellow Sesquile Ramon, and Senator The AAI Committee on Public Affairs (CPA) hosted Government Elizabeth Warren a session, entitled “Funding for Immunology Research: Affairs.
Load more

Recommended publications
  • CPI Newsletter – June 2018
    Mail Stop 2404 • College Station, TX 77843-2404 • (979) 862-9166 • [email protected] ------------------------------------------------------------------------------------ CPI Newsletter – June 2018 ------------------------------------------------------------------------------------ Included in this issue: ⎯ Update from the CPI Chair ⎯ Huffines Faculty Research Seed Grants – Deadline June 15, 2018 ⎯ Potential Opportunity for NSF and NIH Supplements to Existing Grants ⎯ Export Controls Designated Liaison Network ⎯ 3rd Annual Postdoctoral Research Symposium – September 19, 2018 ⎯ Sign Up for Notifications about Limited Submission Proposal Opportunities ⎯ Bulletin for Principal Investigators 2017-18 CPI roster: Chair — Penny Riggs , COALS ● Vice Chair — David Threadgill , Veterinary Medicine ● AgriLife Extension — Craig Carpenter, Gaylon Morgan ● AgriLife Research — Michael Brewer, Ambika Chandra, Fugen Dou, Lee Tarpley ● Architecture — Ergun Akleman ● Bush School — Kent Portney ● COALS — Fuller Bazer, Russell Cross, Martin Dickman, Micky Eubanks, Elizabeth Pierson, David Stelly ● Education – Oi-Man Kwok, Jeffrey Liew ● Engineering — Jorge Alvarado, Ulisses Braga-Neto, Zachary Grasley, Melissa Grunlan, Tony Hsieh Sheng-Jen, Daniel Jiménez, Jodie Lutkenhaus, Ramesh Talreja ● Geosciences — Alejandro Orsi, Pamela Plotkin, Brendan Roark ● IBT/PHARM/RCHI — Julian Hurdle ● Law – Susan Fortney ● Liberal Arts — Sandra Braman, Steve Maren, Harland Prechel ● Mays — Korok Ray ● Medicine —Vytas Bankaitis, Kayla Bayless ● Science — Darren DePoy, Michael Hall,
    [Show full text]
  • Plant Biology '99
    THE NEWSLETTER OF THE AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS Volume 26, Number 1 January/February 1999 Plant Biology '99 III Plant lobs Grab Crabs: Chesapeake Boy Crabs Await You 01 Plant Biology '99! Photo courtesy of Baltimore Areo Convention &Visitors Association. Join your colleagues in celebrating ASPP's SYMPOSIA 75th Anniversary at Plant Biology '99 in Baltimore, Maryland, on July 24-28! Auxin Biology Organizers: Mark Estelle and Ottaline Leyser ASPP's 75th Anniversary Meeting Events: Cell Cycle Regulation Organizer: Tom Jacobs Special President's Symposium functional Plant Genomics Banquet Honoring Past Officers, Award Winners, & Organizer: JeffBennetzen ASPP Traditions Biochemical Genetics Organizer: Dean Della Penna Chesapeake Bay Crab & Chicken Feast President's Symposium: Global Issues in Plant Biology ASPP Family Tree Organizer: Brian Larkins Speakers: Peter Raven, Lester Brown, and Extended Poster Sessions Robert Fraley INSIDE ... i T ASPP-Sponsored Workshop in Greece . ' '~. I' T Novartis, UC-Berkeley Plant Scientists Reach $25 Million Research Collaboration T Call for Nominations for Officers and Awards ASPP Future ASPP Annual Meetings OFFICERS & STAFF .CONTENTS flresident Brian A. Larkins .".""""""" """.. 520·621·9958 1 flresident·Elect .·Plant Biology '99 Deborah Delmer """"""" .."""""""""""""""",,, 530·752·7561 1999 Immediate flost flresident ·3 '" . Ken Keegstra .."""""""""""" ..""""""""""""",517·353·2770 Saturday, July 24, through Secretory . ASPP-Sponsored Workshop in Greece Daniel R. Bush ""......,.."""""""""", ..,..""""""", 217·333·6109 Wednesday, July 28 Treasurer ;MbnagingEditor of Plant Physiology Terri Lomax ."""" .."........."""""""""""."""""", 541·737·5278 .Resigns ' Baltimore, Maryland Choir, Boord of Trustees Douglas D. Randall .........".""""""....."..."""""" 573·882·4847 ASPP's 75th anniversary Choir, flublications Committee 4 . Rebella Chasan .."""""""..."......."""""""""""" 202·628·1500 Public Affairs .' '. meeting Choir, Committee on the -NSF's $85 Millibn in Awards Status of Women in fllont flhysio/ogy Ann M.
    [Show full text]
  • Annual Report Fy 2018 Human Frontier Science Program Organization
    APRIL 2017 APRIL 2018 — MARCH 2019 ANNUAL REPORT FY 2018 HUMAN FRONTIER SCIENCE PROGRAM ORGANIZATION The Human Frontier Science Program Organization (HFSPO) is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. Special emphasis is given to the support and training of independent young investigators, beginning at the postdoctoral level. The Program is implemented by an international organisation, supported financially by Australia, Canada, France, Germany, India, Italy, Japan, the Republic of Korea, New Zealand, Norway, Singapore, Switzerland, the United Kingdom of Great Britain and Nothern Ireland, the United States of America, and the European Commission. Since 1990, over 7000 researchers from more than 70 countries have been supported. Of these, 28 HFSP awardees have gone on to receive the Nobel Prize. 2 The following documents are available on the HFSP website www.hfsp.org: Joint Communiqués (Tokyo 1992, Washington 1997, Berlin 2002, Bern 2004, Ottawa 2007, Canberra 2010, Brussels 2013, London 2016): https://www.hfsp.org/about/governance/membership Statutes of the International Human Frontier Science Program Organization: https://www.hfsp.org/about/governance/hfspo-statutes Guidelines for the participation of new members in HFSPO: https://www.hfsp.org/about/governance/membership General reviews of the HFSP (1996, 2001, 2006-2007, 2010, 2018): https://www.hfsp.org/about/strategy/reviews Updated and previous lists of awards, including titles and abstracts:
    [Show full text]
  • Shigekazu Nagata Is Better Known for His Work on Apoptosis
    © 2001 Nature Publishing Group http://medicine.nature.com NEWS Having originally researched the activities of the potent hematopeotic stimulator of bone-marrow cells, granulocyte colony stimulating factor, Shigekazu Nagata is better known for his work on apoptosis. Here, one of Japan’s most renowned biomedical scientists outlines the path that has taken him full circle: from stimulating cells to grow, to finding out how they die, to tying the two processes together. Shigekazu Nagata For a man who spends most of his time clusively activated in apoptosis. He says Charles Weissmann. He took the job be- thinking about death, Shigekazu Nagata is there are several questions left to be an- cause at that time, “almost no one was remarkably upbeat. For over a decade, he swered concerning the Fas pathway. using recombinant DNA technology in has been making a name for himself with Central among them is, how does the onco- Japan.” He credits his experience in research on apoptosis, the mechanism of gene product Bcl-2 block apoptosis? Weissman’s lab with forming the basis for programmed cell death, and during that However, he has no personal plans to work his future studies and teaching him an “or- time he has watched the field come alive. on an answer to that question, perhaps be- derliness and logical procedure” to re- “Medline publications on apoptosis have cause he has become a victim of his own search. In 1982, he returned to IMS for a risen from only a couple of hundred in success at propagating interest in cell death. short time before moving to the OBI in 1990 to over 10,000 this year,” he says with “There are so many other 1987 and then to taking up a satisfied nod.
    [Show full text]
  • A Sublethal ATP11A Mutation Associated with Neurological Deterioration Causes Aberrant Phosphatidylcholine Flipping in Plasma Membranes
    A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranes Katsumori Segawa, … , Shigeo Kure, Shigekazu Nagata J Clin Invest. 2021. https://doi.org/10.1172/JCI148005. Research In-Press Preview Cell biology Metabolism Graphical abstract Find the latest version: https://jci.me/148005/pdf A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranes Katsumori Segawa,1,16,17 Atsuo Kikuchi,2,16 Tomoyasu Noji,3 Yuki Sugiura,4 Keita Hiraga,3 Chigure Suzuki,5,6 Kazuhiro Haginoya,7,8 Yasuko Kobayashi,7,9 Mitsuhiro Matsunaga,1 Yuki Ochiai,1 Kyoko Yamada,1 Takuo Nishimura,1,18 Shinya Iwasawa,2 Wataru Shoji,10 Fuminori Sugihara,11 Kohei Nishino,12 Hidetaka Kosako,12 Masahito Ikawa,13 Yasuo Uchiyama,5,6 Makoto Suematsu,4 Hiroshi Ishikita,3 Shigeo Kure,2,14 Shigekazu Nagata1, 15* 1Laboratory of Biochemistry & Immunology, World Premier International Research Center, Immunology Frontier Research Center, 11Central Instrumentation Laboratory, Research Institute for Microbial Diseases, 13Department of Experimental Genome Research, Research Institute for Microbial Diseases, 15Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan. 2Department of Pediatrics, Tohoku University School of Medicine, 10Frontier Research Institute for Interdisciplinary Sciences, and 14Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan. 3Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. 4Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan. 5Department of Cellular and Molecular Pharmacology, and 6Department of Cellular and Neuropathology, Juntendo University Graduate School of Medicine, Tokyo, Japan. 7Department of Pediatric Neurology, Takuto Rehabilitation Center for Children, Sendai, Miyagi, Japan.
    [Show full text]
  • Current Positions
    Jay Shendure, MD, PhD Updated December 31, 2020 Current Positions Investigator, Howard Hughes Medical Institute Professor, Genome Sciences, University of Washington Director, Allen Discovery Center for Cell Lineage Director, Brotman Baty Institute for Precision Medicine Contact Information E-mail: [email protected] Lab website: http://krishna.gs.washington.edu Office phone: (206) 685-8543 Education • 2007 M.D., Harvard Medical School (Boston, Massachusetts) • 2005 Ph.D. in Genetics, Harvard University (Cambridge, Massachusetts) Research Advisor: George M. Church Thesis entitled “Multiplex Genome Sequencing and Analysis” • 1996 A.B., summa cum laude in Molecular Biology, Princeton University (Princeton, NJ) Research Advisor: Lee M. Silver Professional Experience • 2017 – present Scientific Director Brotman-Baty Institute for Precision Medicine • 2017 – present Scientific Director Allen Discovery Center for Cell Lineage Tracing • 2015 – present Investigator Howard Hughes Medical Institute • 2015 – present Full Professor (with tenure) Department of Genome Sciences, University of Washington, Seattle, WA • 2010 – present Affiliate Professor Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA • 2011 – 2015 Associate Professor (with tenure) Department of Genome Sciences, University of Washington, Seattle, WA • 2007 – 2011 Assistant Professor Department of Genome Sciences, University of Washington, Seattle, WA • 1998 – 2007 Medical Scientist Training Program (MSTP) Candidate Department of Genetics, Harvard Medical School, Boston, WA • 1997 – 1998 Research Scientist Vaccine Division, Merck Research Laboratories, Rahway, NJ • 1996 – 1997 Fulbright Scholar to India Department of Pediatrics, Sassoon General Hospital, Pune, India 1 Jay Shendure, MD, PhD Honors, Awards, Named Lectures • 2019 Richard Lounsbery Award (for extraordinary scientific achievement in biology & medicine) National Academy of Sciences • 2019 Jeffrey M. Trent Lectureship in Cancer Research National Human Genome Research Institute, National Institutes of Health • 2019 Paul D.
    [Show full text]
  • General Report on 8Th IDS
    General Report on 8th IDS I) Local Organizing Committee Toshiaki Hanafusa (President, First Department of Internal Medicine, Osaka Medical College) Tetsuro Kobayashi (Vice President, Third Department of Internal Medicine, Yamanashi University) Hiroshi Ikegami (Osaka University) Akihisa Imagawa (Osaka Medical College) Yasuko Uchigata (Tokyo Women’s Medical University) Eiji Kawasaki (Nagasaki University) Kaichi Kida (Ehime University) Akira Shimada (Keio University) Kazuma Takahashi (Tohoku University) Masao Nagata (Kobe University) Eiichi Makino (Ehime University) Taro Maruyama (Saitama Social Insurance Hospital) II) Overseas Speakers GS. Eisenbarth (Barbara Davis Center UCHSC, USA) E. Gale (Southmead Hospital, Bristol, UK) DM. Harlan (National Institutes of Health, USA) LC. Harrison (The Walter and Eliza Hall Institute of Medical Research, Australia) YS. Park (Hanyang University, Korea) BO. Roep (Leiden University Medical Center, the Netherlands) L. Chatenoud (Paris, France) III) Local Speakers Tadatsugu Taniguchi (Tokyo University) Shigekazu Nagata (Osaka University) Shimon Sakaguchi (Kyoto University) Jun-ichi Miyazaki (Osaka University) Shizuo Akira (Osaka University) IV) Number of Participants 75 from Japan 145 from Overseas (12 accompanying persons) 1 IDS-8 participants list Accom. Country Subtotal Member Non-Member Person Australia 9 6 3 Belgium 1 0 1 Brazil 1 0 1 Canada 4 3 1 1 Denmark 2 1 1 Finland 21 13 8 France 2 2 0 Germany 3 3 0 India 1 0 1 Israel 1 1 0 1 Italy 2 1 1 1 Japan 75 46 29 3 Korea 9 2 7 New Zealand 2 2 0 Norway 2 2 0 1 Spain 2 1 1 Sweden 17 11 6 1 The Czech Republic 2 2 0 The Netherlands 4 3 1 U.K.
    [Show full text]
  • NEWSLETTER VOLUME 34, NUMBER 2 Scientists NIH Budget: a Moving Target Adapting to $1.629 Billion: Amount Republicans in the Biomedical Research
    ASCB M A R C H 2 0 1 1 NEWSLETTER VOLUME 34, NUMBER 2 Scientists NIH Budget: A Moving Target Adapting to $1.629 billion: Amount Republicans in the biomedical research. To join, go to www.ascb. Change U.S. House of Representatives want to cut from org/Project50. Page 3 the U.S. National Institutes of n Become a member of the Health (NIH) FY11 budget Coalition for the Life Sciences’ (compared with FY10) Congressional Liaison Committee Finding the $745 million: Amount U.S. (CLC). Receive alerts on President Obama wants to add important science policy issues, Right Academic to the NIH budget for FY12 help build local support for Career (compared with FY10) biological research, and visit your Page 11 No matter how you look at it, Representative in the House and the news could be better for the Senators. To become a member, NIH budget. While the budget’s go to www.coalitionforlifesciences. Genomics future is uncertain, one thing org/be-an-advocate/about-the-clc/ Revolutionizes isn’t—Congress needs to hear join-the-clc. from you. n Stay informed about science policy by Cell Biology What can you do? Become more involved in reading the ASCB Newsletter’s Public Policy science policy advocacy. Briefings. Page 22 n Join Project 50, the ASCB Public Policy n Stay up-to-date on current advocacy alerts by Advocacy Team. Receive special briefings visiting http://capwiz.com/jscpp/home. n Inside and organize your colleagues in support of —Kevin M. Wilson 2011 Congressional Biomedical Don’t Miss President’s Column 3 Public Policy Briefing 7 Research Caucus Topics iBioMagazine Call for Nominations 9 Each year the Coalition for the Life Sciences (CLS) plans a Issue 3 Dear Labby 10 series of caucuses on Capitol Hill that are designed to foster Join MAC 10 an appreciation for and understanding of biomedical research.
    [Show full text]
  • Appendix Ii –Curricula Vitae
    APPENDIX II –CURRICULA VITAE ROL E NAME (e.g., ICI leader, co-investigator, project manager, etc.) Peter Freeman Executive Director John Chenery Director of Media and Communications Jesse Ausubel Member, Board of Directors Ivar Myklebust Member, Board of Directors Rocky Skeef Member, Board of Directors Steve O’Brien Chair, Science Advisory Board David Haussler Member, Science Advisory Board Paul Thompson Member, Science Advisory Board John McPerson Chair, Technology Development Advisory Group Jay Shendure Member, Technology Development Advisory Group Barton Slatko Member, Technology Development Advisory Group Baoli Zhu Member, Technology Development Advisory Group Christian Brochmann Vice-chair, WG2.4 Greg Singer Chair, WG5.1 Peter Phillips Chair, WG6.2 David Castle Chair, WG6.5 Richard Gold Chair, WG6.3 David Secko Chair, WG6.4 Tania Bubela Chair, WG6.1 Andrew Mitchell Australia representative on the SSC Andrew Lowe Australia alternate on the SSC Thomas Valqui Peru representative on the SSC Gisella Orjeda Peru alternate on the SSC 98 PETER FREEMAN BA, PHD, FIBD 120 Stuart Street, Guelph, Ontario, CANADA N1E 4S8 Phone (W): +1 519 824 4120 Cell: +1 519 731 2163 Email: [email protected] PROFILE Experienced science-based (PhD qualified) executive director, with a track record of successfully co- ordinating large multi-institutional research projects, networks and consortia in genomics, proteomics, stem cell research and population health. Strong financial management, strategic planning and project management skills gained in R&D and operations roles in the international malting and brewing industry Superior mentoring, facilitating, technical writing and editing skills used to develop successful interdisciplinary funding proposals. Fully proficient in information /communication technologies and their use in knowledge translation and public outreach activities.
    [Show full text]
  • Enhanced and Accelerated Lymphoproliferation in Fas
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2131-2136, March 1996 Biochemistry Enhanced and accelerated lymphoproliferation in Fas-null mice MASASHI ADACHI*, SACHIKO SUEMATSUt, TAKASHI SUDA*, DAISUKE WATANABE*, HIDEHIRO FUKUYAMA*, JUN OGASAWARA*, TAKASHI TANAKAt, NOBUAKI YOSHIDAt, AND SHIGEKAZU NAGATA* *Osaka Bioscience Institute, 6-2-4 Furuedai, Suita. Osaka 565. Japan, and 'Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi, Osaka 590-0)2, Japan Communicated by Charles Weissmann, Universitat Ziurich, Zutriclh, Switzerland, November 22, 1995 (received for review Jutne 26, 1995) ABSTRACT Fas is a 45-kDa membrane protein that retrovirus-into an intron of the Fas chromosomal gene transduces an apoptotic signal. The mouse lymphoprolifera- (25-28), which results in premature termination and aberrant tion (lpr) mutation is a leaky mutation of Fas. In this study, splicing of the Fas transcript. However, a small amount of we examined lymphocyte development in Fas-null mice gen- intact Fas mRNA or protein is expressed in the thymus of lpr erated by gene targeting. The Fas-/- mice progressively mice (26, 28, 29), indicating that the lpr mutation is leaky (25). accumulated abnormal T cells (Thyll, B220+, CD4-, and Therefore, it was thought that the absence in lpr mice of altered CD8-) and developed lymphadenopathy and splenomegaly, thymic cell development was related to the leakiness of the which were much more accelerated and pronounced than mutation (29). those in lpr mice. In addition, the Fas-null mice showed To overcome this problem, we created Fas-knockout mice lymphocytosis, accompanied by lymphocytic infiltration in and found that they developed hepatomegaly in addition to the lungs and liver.
    [Show full text]
  • Academy Honors 17 for Major Contributions to Science
    Proc. Natl. Acad. Sci. USA Vol. 96, pp. 1173–1174, February 1999 From the Academy Academy Honors 17 for Major Contributions to Science The National Academy of Sciences has selected 17 in electricity, magnetism, or radiant energy, broadly individuals to receive awards honoring their outstanding interpreted—goes to John Clarke, Luis W. Alvarez contributions to science. The awards will be presented Memorial Chair for Experimental Physics and professor on April 26 at a ceremony in Washington, DC, during the of physics, University of California, Berkeley. Clarke Academy’s 136th annual meeting. Awards and recipients was chosen “for his major contributions to the develop- are as follows: ment of superconducting quantum interference devices (SQUIDS) and their use for scientific measurements, Arctowski Medal—a prize of $20,000, plus $60,000 to an especially involving electricity, magnetism, and electro- institution of the recipient’s choice, awarded every three magnetic waves.” The prize was established through the years to further research in solar physics and solar- Cyrus B. Comstock Fund and has been presented since terrestrial relationships—goes to Arthur J. Hund- 1913. hausen, senior scientist emeritus, High Altitude Obser- vatory, National Center for Atmospheric Research, The Arthur L. Day Prize and Lectureship—a prize of Boulder. Hundhausen was chosen “for his exceptional $20,000 awarded approximately every three years to a research in solar and solar-wind physics, particularly in scientist making new contributions to the physics of the the area of coronal and solar-wind disturbances.” The Earth and whose four to six lectures would prove a solid, medal was established in honor of Henryk Arctowski timely, and useful addition to the knowledge and liter- and has been awarded since 1969.
    [Show full text]
  • WILLSCOT CORPORATION (Formerly Known As Double Eagle Acquisition Corp.) (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to WILLSCOT CORPORATION (formerly known as Double Eagle Acquisition Corp.) (Exact name of registrant as specified in its charter) Delaware 001-37552 82-3430194 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification No.) incorporation) 901 S. Bond Street, #600 Baltimore, Maryland 21231 (Address, including zip code, of principal executive offices) (410) 931-6000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Name of Each Exchange on Which Registered Class A Common Stock, par value $0.0001 per share NASDAQ Capital Market Warrants, each exercisable for one-half of one share of Class A NASDAQ Capital Market Common Stock Securities registered pursuant to Section 12(g) of the Act: None. Indicate by check mark if the registrant is a well known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No 1 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]